Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Press Release Clearside Biomedical Receives Notification Of Fda Acceptance Of Nda Filing For Xipere Triamcinolone Acetonide Ophthalmic Suspension For Suprachoroidal Injection With Pdufa Date Set For October 19 2019 is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today ... Read More
Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer
March 18, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal .. Read More
Benralizumab Receives FDA Approval as Add-On Maintenance Therapy for Children With Severe Asthma
The FDA has approved benralizumab (Fasenra) for children aged 6 to 11 years with severe eosinophilic asthma, according to an AstraZeneca press release. 1 Benralizumab was first approved in 2017 as ... Read More
Triamcinolone Acetonide: How You Can Use It to Treat Eczema
Triamcinolone acetonide (TA) is a corticosteroid medication ... The Food and Drug Administration (FDA) provides information on topical TA dosage and administration. However, always follow the ... Read More
SunPower Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K
This press release contains "forward-looking statements ... Company's statements regarding the Company's ability to complete the filing of the Form 10-K within a specific time period and the ... Read More
Press release: Orange issues 700 million euros of hybrid notes
Orange S.A. (the Company) successfully priced the issuance of €700 million undated deeply subordinated fixed to reset rate notes with a first call date ... to set the Series Maximum Acceptance ... Read More
Dustborn Receives an August Release Date
Read Thread Games has unveiled the release date for their upcoming game Dustborn ... of variety to be found in the game. Dustborn is set to release on August 20 for PC, Xbox, and PlayStation ... Read More
Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer
Clearside developed and gained approval for its first product, XIPERE® (triamcinolone acetonide injectable suspension) for suprachoroidal ... only as of the date of this press release and are ... Read More
Dustborn Receives an August Release Date
Red Thread Games' road trip adventure Dustborn now has a release date, unveiled at the Future ... variety to be found in the game. Dustborn is set to release on August 20 for PC, Xbox, and ... Read More
Clearside Biomedical, Inc.: Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer
Clearside developed and gained approval for its first product, XIPERE® (triamcinolone acetonide injectable suspension) for suprachoroidal ... only as of the date of this press release and are ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus